Director James Forbes buys 5,000 DENTSPLY SIRONA (XRAY) shares

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director James D. Forbes reported an open-market purchase of common stock. On March 9, 2026, he bought 5,000 shares at $12.48 per share. After this transaction, his directly owned position increased to 10,000 common shares of the company.

Insider Trade Summary

Net Buyer: 5,000 shares ($62,400)

Net Buy 1 txn

Insider Forbes James D

Role Director

Bought 5,000 shs ($62K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,000	$12.48	$62K

Holdings After Transaction: Common Stock — 10,000 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Forbes James D

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		P		5,000	A	$12.48	10,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for James D. Forbes	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) report for James D. Forbes?

Director James D. Forbes reported an open-market purchase of DENTSPLY SIRONA common stock. He bought 5,000 shares at $12.48 per share, increasing his directly owned holdings to 10,000 shares following the transaction disclosed in this Form 4 filing.

How many DENTSPLY SIRONA shares did James D. Forbes buy and at what price?

James D. Forbes purchased 5,000 shares of DENTSPLY SIRONA common stock. The open-market transaction was executed at a price of $12.48 per share, as reported in the Form 4 insider trading disclosure for the director.

What is James D. Forbes’ DENTSPLY SIRONA share ownership after this Form 4 transaction?

After the reported trade, James D. Forbes directly owns 10,000 DENTSPLY SIRONA common shares. This reflects an increase from his prior holdings, following the open-market purchase of 5,000 shares disclosed in the Form 4 filing.

Was the DENTSPLY SIRONA insider trade by James D. Forbes a purchase or a sale?

The transaction reported by James D. Forbes was a purchase. The Form 4 classifies it as an open-market acquisition of 5,000 DENTSPLY SIRONA common shares at $12.48 per share, rather than a sale or disposition of existing holdings.

What type of security did James D. Forbes acquire in the DENTSPLY SIRONA Form 4?

James D. Forbes acquired DENTSPLY SIRONA Inc. common stock. The Form 4 lists a non-derivative transaction involving 5,000 shares of common stock, purchased in the open market at a transaction price of $12.48 per share.